Transient Receptor Potential Melastatin 3 Is Functionally Expressed in Oligodendrocyte Precursor Cells and Is Upregulated in Ischemic Demyelinated Lesions-Reference-Cited by-同舟云学术

Transient Receptor Potential Melastatin 3 Is Functionally Expressed in Oligodendrocyte Precursor Cells and Is Upregulated in Ischemic Demyelinated Lesions

Published:2021-02-01 Issue:2 Volume:44 Page:181-187
ISSN:0918-6158
Container-title:Biological and Pharmaceutical Bulletin
language:en
Short-container-title:Biol. Pharm. Bull.

Author:

Ohashi Kana¹,Shibasaki Koji²,Nakazawa Hayaki¹,Kunimasa Ryotaro¹,Nagayasu Kazuki¹,Shirakawa Hisashi¹,Kaneko Shuji¹

Affiliation:

1. Department of Molecular Pharmacology, Graduate School of Pharmaceutical Sciences, Kyoto University

2. Division of Neurochemistry, Graduate School of Human Health Science, University of Nagasaki

Publisher

Pharmaceutical Society of Japan

Subject

Pharmaceutical Science,Pharmacology,General Medicine

Link

https://www.jstage.jst.go.jp/article/bpb/44/2/44_b20-00510/_pdf

Reference45 articles.

1. 1) Dimou L, Gallo V. NG2-glia and their functions in the central nervous system. Glia, 63, 1429–1451 (2015).

2. 2) Iijima K, Kurachi M, Shibasaki K, Naruse M, Puentes S, Imai H, Yoshimoto Y, Mikuni M, Ishizaki Y. Transplanted microvascular endothelial cells promote oligodendrocyte precursor cell survival in ischemic demyelinating lesions. J. Neurochem., 135, 539–550 (2015).

3. 3) Xu S, Lu J, Shao A, Zhang JH, Zhang J. Glial cells: role of the immune response in ischemic stroke. Front. Immunol., 11, 294 (2020).

4. 4) Sypecka J, Sarnowska A. The neuroprotective effect exerted by oligodendroglial progenitors on ischemically impaired hippocampal cells. Mol. Neurobiol., 49, 685–701 (2014).

5. 5) Seo JH, Miyamoto N, Hayakawa K, Pham LD, Maki T, Ayata C, Kim KW, Lo EH, Arai K. Oligodendrocyte precursors induce early blood–brain barrier opening after white matter injury. J. Clin. Invest., 123, 782–786 (2013).

Cited by 4 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. TRP channels as potential target molecules for pharmacotherapy of neurological diseases;TRP Channels as Therapeutic Targets;2024

2. TRPM3: An emerging pain target (and more);TRP Channels as Therapeutic Targets;2024

3. Specific Cellular Effects of Low Bortezomib Concentrations on Purified Cultures of Schwann Cells, Satellite Glial Cells, Macrophages, and Dorsal Root Ganglion Neurons;Biological and Pharmaceutical Bulletin;2023-01-01

4. TRPM3 in the eye and in the nervous system – from new findings to novel mechanisms;Biological Chemistry;2022-03-02